Profile data is unavailable for this security.
About the company
iZafe Group AB, formerly MediRatt AB, is a Sweden-based company that conducts research, development and marketing of medical products for medication and drug management. Its offering includes Dosell, a patented drug dispenser under development that can be used when medicating patients at home via remote monitoring; and MediKoll, an app that provides patients information about side effects, reactions and allergies linked to different types of medication. The Company operates in the pharmaceutical industry, hospitals and care homes, and Pharmacies and private healthcare markets. It is active globally.
- Revenue in SEK (TTM)6.29m
- Net income in SEK-31.99m
- Incorporated2008
- Employees7.00
- LocationiZafe Group ABSodra Fiskartorpsvagen 20STOCKHOLM 114 33SwedenSWE
- Phone+46 8211121
- Fax+46 87656633
- Websitehttps://izafe.se/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| BBS-Bioactive Bone Substitutes Oyj | 0.00 | -41.19m | 28.58m | -- | -- | 0.5269 | -- | -- | -0.2069 | -0.2069 | 0.00 | 0.1765 | 0.00 | -- | -- | -- | -35.38 | -25.12 | -45.41 | -28.54 | -- | -- | -- | -- | -- | -27.51 | 0.5953 | -- | -- | -- | -12.64 | -- | -- | -- |
| ProstaLund AB | 16.22m | -19.84m | 28.67m | 7.00 | -- | 0.4951 | -- | 1.77 | -0.2328 | -0.2328 | 0.1807 | 0.4706 | 0.243 | 0.3281 | 6.67 | -- | -29.73 | -29.14 | -33.53 | -35.01 | 70.50 | 75.26 | -122.35 | -68.94 | 2.60 | -135.86 | 0.0175 | -- | 27.54 | 10.36 | -53.27 | -- | 20.35 | -- |
| Inhalation Sciences Sweden AB | 15.48m | -3.93m | 31.55m | 8.00 | -- | 2.81 | -- | 2.04 | -0.2796 | -0.2796 | 1.09 | 0.7409 | 0.8096 | 0.6328 | 4.37 | 1,935,000.00 | -20.53 | -27.93 | -29.23 | -43.82 | 86.29 | 71.13 | -25.36 | -48.02 | 2.81 | -6.49 | 0.0639 | -- | 43.55 | 26.33 | 60.87 | -- | -- | -- |
| Bio Vitos Pharma AB | 1.01m | -15.13m | 32.78m | 1.00 | -- | 0.8735 | -- | 32.43 | -0.7859 | -0.7859 | 0.0393 | 0.9525 | 0.0271 | 0.2064 | 19.99 | 1,010,830.00 | -40.53 | -31.11 | -54.83 | -32.92 | 89.68 | -- | -1,496.73 | -1,026.76 | 2.28 | -- | 0.00 | -- | 126.97 | -- | 13.64 | -- | -- | -- |
| PMD Device Solutions AB | 51.91m | -43.42m | 33.21m | 37.00 | 0.2528 | -- | -- | 0.6397 | 5.06 | 5.06 | 3.54 | -5.52 | 0.8624 | -- | 4.47 | -- | -72.13 | -- | -- | -- | 82.86 | -- | -83.64 | -- | 0.1121 | -1.88 | -- | -- | -- | -- | -- | -- | -- | -- |
| Scandinavian ChemoTech AB | 5.03m | -15.70m | 37.74m | 5.00 | -- | 4.53 | -- | 7.50 | -0.8655 | -0.8655 | 0.2647 | 0.384 | 0.3162 | 0.5947 | 1.37 | 838,666.70 | -98.64 | -87.29 | -98.64 | -118.55 | 29.67 | 252.05 | -311.96 | -2,122.77 | -- | -22.93 | 0.00 | -- | 496.62 | 19.13 | 7.28 | -- | -- | -- |
| Scandinavian Real Heart AB | 0.00 | -75.02m | 37.85m | 12.00 | -- | 0.4136 | -- | -- | -51.82 | -51.82 | 0.00 | 44.25 | 0.00 | -- | -- | 0.00 | -73.46 | -24.27 | -87.03 | -26.81 | -- | 832.41 | -- | -6,070.11 | -- | -700.38 | 0.1023 | -- | -100.00 | -- | -385.97 | -- | -25.76 | -- |
| Phase Holographic Imaging PHI AB | 9.12m | -21.81m | 52.19m | 14.00 | -- | -- | -- | 5.72 | -0.8695 | -0.8695 | 0.3634 | -0.0273 | 0.2373 | 0.6598 | 1.18 | 651,571.40 | -56.73 | -62.04 | -88.25 | -79.16 | 71.06 | 63.16 | -239.04 | -328.50 | 0.1916 | -5.61 | 1.04 | -- | 6.16 | 17.96 | 12.98 | -- | 22.76 | -- |
| Clinical Laserthermia Systems AB | 18.63m | -64.20m | 52.65m | 7.00 | -- | 0.862 | -- | 2.83 | -7.93 | -7.93 | 2.05 | 4.39 | 0.265 | 7.62 | 5.22 | -- | -92.16 | -123.49 | -103.14 | -312.95 | -175.42 | -1,084.16 | -347.76 | -1,625.03 | 2.39 | -11.71 | 0.0077 | -- | 31.99 | 35.55 | -12.92 | -- | 18.26 | -- |
| iZafe Group AB | 6.29m | -31.99m | 55.00m | 7.00 | -- | 3.53 | -- | 8.75 | -0.1319 | -0.1319 | 0.0259 | 0.0567 | 0.1602 | 3.25 | 12.26 | 898,285.70 | -81.49 | -52.17 | -100.43 | -69.40 | -116.33 | -198.20 | -508.73 | -487.50 | 0.4406 | -43.46 | 0.3159 | -- | 149.93 | -24.79 | -36.76 | -- | -41.66 | -- |
| ScandiDos AB | 61.35m | -9.67m | 74.80m | 26.00 | -- | 2.14 | -- | 1.22 | -0.2068 | -0.2068 | 1.26 | 0.766 | 0.8184 | 1.31 | 6.88 | 1,978,871.00 | -12.90 | -12.60 | -23.54 | -21.76 | 50.39 | 51.58 | -15.76 | -15.37 | 0.9476 | -6.36 | 0.00 | -- | -1.82 | 4.36 | -60.62 | -- | -19.29 | -- |
| Ortivus AB | 77.96m | -17.79m | 81.55m | 32.00 | -- | 33.49 | -- | 1.05 | -0.4016 | -0.4016 | 1.76 | 0.0538 | 0.9036 | -- | 23.27 | 1,949,050.00 | -20.62 | -2.41 | -41.25 | -4.63 | 36.38 | 42.46 | -22.82 | -1.77 | 0.4251 | -7.58 | 0.9447 | -- | -19.55 | 10.00 | -409.66 | -- | 67.43 | -- |
Data as of Nov 22 2024. Currency figures normalised to iZafe Group AB's reporting currency: Swedish Krona SEK
0.01%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| FCG Fonder ABas of 31 Oct 2024 | 26.12k | 0.01% |
Data from 31 Oct 2024 - 31 Oct 2024Source: FactSet Research Systems Inc.
